MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

Sep 2014| BIO115B| BCC Publishing

Report Highlights

The global market for microRNA (miRNA) research tools, services, diagnostics and drug discovery was valued at $478.8 million in 2013. This market is expected to reach $572 million in 2014 and $1 billion in 2019, at a compound annual growth rate (CAGR) of 12.6% for the period of 2014 to 2019.

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics with an analysis of the commercial potential of this research field.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, HCV infection, and cardiovascular diseases.
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments.
  • Identification of the main markets for RNA therapeutics.

Report Scope

This BCC Research report is a business tool that is intended to help biotechnology companies evaluate emerging commercial opportunities in the microRNA reagent, diagnostic and therapeutic submarkets. The existing leading players in this market segment are provided with an opportunity to learn what the other competitors in this nascent arena have achieved to gain a stronger foothold in the sector in their quest for bringing to the market blockbuster therapeutics to treat diseases with significant unmet medical needs.

Analyst Credentials

P. Natana Raj is a medical analyst and has edited 25 market research reports in the past nine years, covering pharmaceuticals, medical devices, stem cells, regenerative medicine and beverages. He is a retired college professor with 32 years of experience in teaching biochemistry, biotechnology, biochemical pharmacology, molecular biology and genetics. In addition to his Master of Science degree in Biology, he also holds diplomas in biochemistry, biochemical pharmacology, biotechnology and environmental biology.

Frequently Asked Questions (FAQs)

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets273Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: INTRODUCTION TO MICRORNA RESEARCH28Free
Chapter- 4: MICRORNA-TARGETED THERAPEUTICS: AN OVERVIEW13Free
Chapter- 5: MICRORNA SERVICE SECTOR: AN OVERVIEW18Free
Chapter- 6: MICRORNA IN DIAGNOSTICS: AN OVERVIEW12Free
Chapter- 7: BIOINFORMATICS: APPLICATIONS IN MICRORNA RESEARCH10Free
Chapter- 8: MICRORNA TECHNOLOGIES: AN OVERVIEW100Free
Chapter- 9: SUMMARY OF TOOLS AND REAGENTS MARKET IN MICRORNA RESEARCH2Free
Chapter- 10: MARKET SUMMARY FOR MICRORNA RESEARCH TOOLS, SERVICES, DIAGNOSTICS AND DRUG DISCOVERY PRODUCT DEVELOPMENT4Free
Chapter- 11: SELECTED COMPANY PROFILES78Free
Chapter- 12: APPENDIX: ACRONYMS AND ABBREVIATIONS3Free
Published - Nov-2012| Analyst - Marianna Tcherpakov| Code - BIO115A

Report Highlights

The global microRNA research tools market was valued at nearly $295.1 million in 2011 and should reach nearly $338.3 million in 2012. Total market value is expected to reach $763 million in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 17.7%.

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics with an analysis of the commercial potential of this research field
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, HCV infection, and cardiovascular diseases
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments during the last two years
  • Forecasts of the future situation and major drawbacks of the miRNA drug development model and possible solutions for these obstacles, especially in context of drug stability and delivery
  • Identification of the main markets for RNA therapeutics
  • Comprehensive company profiles of major players in the industry.
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS